article thumbnail

Driving Dosage Form Developments

PharmaTech

Dosage forms are being shaped by numerous factors, with patient-centricity continuing to be an important driver of decisions in development.

Dosage 116
article thumbnail

With little FDA oversight, melatonin supplements vary widely in actual dosage, study finds

STAT

WASHINGTON — Consumers turning to melatonin gummies to get some help falling asleep might be getting a lot more help than they bargained for, according to a new study published Tuesday in the Journal of the American Medical Association.

Dosage 246
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Reshaping Dosage Forms

PharmaTech

Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Dosage 98
article thumbnail

STAT+: Lawmaker accuses Amgen of placing profits above patients with dosing for a cancer drug

STAT

At the time, the Food and Drug Administration required Amgen to run a trial confirming earlier test results, as well as a so-called post-marketing study to examine safety and effectiveness at different dosages, in order to gain full approval. Continue to STAT+ to read the full story…

Dosage 349
article thumbnail

STAT+: Oral ketamine tablets effective for treating depression, new study finds

STAT

In the Phase 2 trial, the results of which were detailed in Nature Medicine , patients who took extended release ketamine tablets at an 180mg dosage twice weekly showed a “statistically significant and clinically meaningful improvement in depressive symptoms” compared to a placebo. Other dosages saw less of an impact.

Dosage 308
article thumbnail

STAT+: Airway disease drug from Insmed succeeds in one of the year’s most anticipated trials

STAT

The trial, called the ASPEN study, tested two dosages of the drug, and the company said both significantly cut rates of pulmonary exacerbations.     The drug, brensocatib, reduced so-called pulmonary exacerbations by roughly 20% versus placebo in patients with bronchiectasis, hitting the trial’s primary endpoint.

Dosage 330
article thumbnail

Edible sensor delivers real-time antiretroviral dosage data

European Pharmaceutical Review

An innovative ingestible sensor technology tested in an interventional clinical trial provided HIV patients with real-time antiretroviral dosage data , enabling them to better control their infection. The post Edible sensor delivers real-time antiretroviral dosage data appeared first on European Pharmaceutical Review.

Dosage 112